These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12509709)

  • 1. Cystic fibrosis carrier screening: issues in implementation.
    Watson MS; Desnick RJ; Grody WW; Mennuti MT; Popovich BW; Richards CS
    Genet Med; 2002; 4(6):407-9. PubMed ID: 12509709
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.
    Watson MS; Cutting GR; Desnick RJ; Driscoll DA; Klinger K; Mennuti M; Palomaki GE; Popovich BW; Pratt VM; Rohlfs EM; Strom CM; Richards CS; Witt DR; Grody WW
    Genet Med; 2004; 6(5):387-91. PubMed ID: 15371902
    [No Abstract]   [Full Text] [Related]  

  • 3. Carrier screening, incidence of cystic fibrosis, and difficult decisions.
    Liou TG; Rubenstein RC
    JAMA; 2009 Dec; 302(23):2595-6. PubMed ID: 20009063
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutation distribution in expanded screening for cystic fibrosis: making up the balance in a context of ethnic diversity.
    Schrijver I
    Clin Chem; 2011 Jun; 57(6):799-801. PubMed ID: 21474640
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal screening for cystic fibrosis: an early report card.
    Palomaki GE
    Genet Med; 2004; 6(3):115-6. PubMed ID: 15354327
    [No Abstract]   [Full Text] [Related]  

  • 6. The expanding phenotype of cystic fibrosis.
    Smith JM; Kirk EP
    Med J Aust; 2004 Nov; 181(9):514. PubMed ID: 15516201
    [No Abstract]   [Full Text] [Related]  

  • 7. Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function.
    Massie J; Castellani C; Grody WW
    Lancet; 2014 Mar; 383(9920):923-5. PubMed ID: 23992917
    [No Abstract]   [Full Text] [Related]  

  • 8. Cystic fibrosis.
    Welsh MJ; Smith AE
    Sci Am; 1995 Dec; 273(6):52-9. PubMed ID: 8525348
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystic fibrosis carrier screening in a North American population.
    Zvereff VV; Faruki H; Edwards M; Friedman KJ
    Genet Med; 2014 Jul; 16(7):539-46. PubMed ID: 24357848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CF gene: 10 years on.
    Geddes DM; Alton EW
    Thorax; 1999 Dec; 54(12):1052-4. PubMed ID: 10567621
    [No Abstract]   [Full Text] [Related]  

  • 11. Diversity of cystic fibrosis mutation-screening practices.
    Grody WW; Desnick RJ; Carpenter NJ; Noll WW
    Am J Hum Genet; 1998 May; 62(5):1252-4. PubMed ID: 9545412
    [No Abstract]   [Full Text] [Related]  

  • 12. Conclusion and Prospects: Genetics of cystic fibrosis - an agenda for the next ten years.
    Castellani C
    Arch Pediatr; 2020 Feb; 27 Suppl 1():eS45-eS47. PubMed ID: 32172938
    [No Abstract]   [Full Text] [Related]  

  • 13. [The example of cystic fibrosis to highlight the complexity of genetic screening].
    Bochud M; Fellmann F; Vader JP; Grosse S; Paccaud F; Guessous I
    Rev Med Suisse; 2010 Jul; 6(256):1395-9. PubMed ID: 20701015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between cystic fibrosis and bronchiectasis and its research implications in Chinese].
    Li HP; He GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):627-9. PubMed ID: 15498278
    [No Abstract]   [Full Text] [Related]  

  • 15. Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.
    Scriver CR; Fujiwara TM
    Am J Hum Genet; 1992 Nov; 51(5):943-50. PubMed ID: 1384327
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of CFTR mutations in Saguenay- Lac-Saint-Jean: proposal of a panel of mutations for population screening.
    Madore AM; Prévost C; Dorfman R; Taylor C; Durie P; Zielenski J; Laprise C
    Genet Med; 2008 Mar; 10(3):201-6. PubMed ID: 18344710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening oocyte donors for cystic fibrosis using multiplex PCR amplification of the CFTR gene from buccal cell DNA.
    Chang PL; Lindheim SR; Sauer MV
    J Assist Reprod Genet; 1998 Jul; 15(6):405-6. PubMed ID: 9673888
    [No Abstract]   [Full Text] [Related]  

  • 18. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the prevalence of cystic fibrosis in the United Arab Emirates by genetic carrier screening.
    Frossard PM; Lestringant G; Girodon E; Goossens M; Dawson KP
    Clin Genet; 1999 Jun; 55(6):496-7. PubMed ID: 10450871
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular temporal bone pathology: III. Genotyping of the deltaF508 deletion in the DNA of patients with cystic fibrosis.
    Wackym PA; Kerner MM; Grody WW
    Laryngoscope; 1998 Aug; 108(8 Pt 2 Suppl 88):1-3. PubMed ID: 9707259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.